parental blood pressure has been measured. It is interesting, however, that the relation between birth weight, maternal age, and birth rank and blood pressure were largely unaffected by adjustment for reported parental history of high blood pressure and seemed to be similar in children with and without a maternal history of hypertension. These findings suggest that the means by which familial influences on blood pressure are mediated are quite separate from those of the other factors discussed. Objective-To determine whether rates of road traffic accidents were higher in diabetics treated with insulin than in non-diabetic subjects.
Setting-Diabetic, dermatology, and gastroenterology outpatient clinics.
Patients-596 Diabetics treated with insulin (354 drivers) aged attending two clinics and 476 non-diabetic outpatients (302 drivers).
Main outcome measures-Rates of accidents in diabetic and non-diabetic subjects.
Results-A self completed questionnaire was used to record age, sex, driving state, and rates of accidents and convictions for motoring offences among diabetic and non-diabetic volunteers. For the diabetic volunteers further information was obtained on treatment, experience of hypoglycaemia, and declaration of disability to the Driving and Vehicle Licensing Centre and their insurance company. Accident rates were similar (81 (23%) diabetic and 76 (25%) non-diabetic drivers had had accidents in the previous five years). A total of 103 diabetic drivers had recognised hypoglycaemic symptoms while driving during the previous year. Only 12 reported that hypoglycaemia had ever caused an accident. Overall, 249 had declared their diabetes to an insurance company. Of these, 107 had been required to pay an increased premium, but there was no excess of accidents in this group. Conclusions-Diabetic drivers treated with insulin and attending clinics have no more accidents than non-diabetic subjects and may be penalised unfairly by insurance companies.
Introduction
Diabetes mellitus in drivers of motor vehicles is assumed to be a potential danger both to the driver and to other road users. This belief stems from both the immediate disabling effects of hypoglycaemia and the long term implications of the disease, particularly retinopathy. With these problems diabetics might be expected to have more road traffic accidents than the general population, but available evidence is conflicting. Early studies from the United States have consistently shown higher accident rates for diabetic motorists,'"3 but Ysander's work showed reduced rates among Swedish diabetic drivers. 4 We could not find a comparable controlled study in the United Kingdom, but recent evidence has suggested that insulin dependent diabetic drivers have no excess of accidents. 5 We compared rates of road traffic accidents among diabetic drivers taking insulin and non-diabetic drivers. We also assessed the motoring practices of diabetic drivers and the attitudes of insurance companies towards them.
Subjects and methods
A complete census of insulin dependent and noninsulin dependent diabetic patients, aged 18-65 inclusive on 1 October 1986, who had been taking insulin for at least one year was carried out at two diabetic clinics in Belfast. During an initial period of four months individual patients were recruited when they attended their respective clinic. A further eight months' follow up was required to recruit subjects who did not attend in the initial four months. Patients gave informed oral consent before participating in the survey, which had been approved by the ethical committee of Queen's University, Belfast. Each volunteer completed a confidential questionnaire under supervision by one of us.
The questionnaire was divided into three sections. In the first section personal and clinical details were recorded by the supervisor. The second and third sections contained multiple choice questions and questions requiring simple yes/no answers. Some questions also required subjects to give brief written details. The second section asked for information on home monitoring of blood glucose concentration, experience of hypoglycaemia, and alcohol consumption. In the third section the current driving state of patients was established. All patients who at the time of the survey drove motor vehicles on public roads were asked for details of their driving experience. The numbers of accidents and driving convictions since starting insulin treatment, and becoming a motorist or during the past five years, whichever was the shorter, were recorded. An accident was defined as any road traffic accident that resulted in injury, a vehicle requiring repairs in a garage, or an insurance claim, or any combination. All such accidents in which the subject was the driver, whether or not he or she was at fault, were included. Patients were asked about their experience with hypoglycaemia while driving. They were asked whether they had declared their condition to the Driving and Vehicle Licensing Centre and their insurance company. Information was then sought on the attitudes ofinsurance companies to diabetic drivers. Finally, each diabetic driver was assessed on knowledge of the relevant legislation and the recommendations of the British Diabetic Association for drivers. Visual acuity was measured by using a Snellen chart with the subject wearing spectacles if these were normally worn for driving.
A (13) years). Table I shows that diabetic drivers had held driving licences for longer and that alcohol consumption was greater among non-diabetic drivers. The table SX2=O-00, p=0-97.
also shows that the distribution of other variables (annual distance driven and usual driving area) was similar in the two groups.
Fifty (8-4%) diabetics who were non-drivers at the time of the survey had been drivers in the past. Fifteen of these had stopped driving for reasons directly associated with diabetes mellitus: five because of retinopathy and inadequate visual acuity, six because of hypoglycaemia, and four simply because they had diabetes. Five others had stopped driving as a result of peripheral or cardiovascular disease. Three diabetic drivers had given up for medical reasons unrelated to diabetes. Forty nine (10-3%) non-diabetic subjects had been drivers in the past, seven having given up for medical reasons.
Accidents and motoring offences-The numbers of drivers from each group reporting accidents was not significantly different. Eighty two (23 2%) diabetic drivers and 75 (24-8%) non-diabetic drivers had had one or more accidents during the five years (table II) . Analysis with Cochran's method stratified for age and BMJ VOLUME 299 x2=7-07, p=0 03. sex, duration of holding a driving licence, and alcohol consumption did not substantially alter the difference in accident rates. Accident rates calculated per 1 5 million km, per 100 driver years, and per 100 drivers were similar (table III) . The difference in the numbers of convictions for motoring offences between the two groups was not significant. Thirteen (4%) diabetic drivers and 20 (7%) non-diabetic drivers had had at least one conviction during the five years.
Medical state of drivers-Of the diabetic motorists who were driving at the time of the study, 99 (28%) had medical conditions other than diabetes. Twenty three of this group had had one or more accidents compared with 59 (23%) of the diabetic drivers without other medical conditions. Within the group of diabetic drivers there were 17 who had a known history of ischaemic heart disease, five of whom had had accidents during the five years. Only eight non-diabetic drivers had a history of ischaemic heart disease, two of these having had an accident. No drivers in either group admitted to having epilepsy. Seventeen diabetic drivers had visual acuity, with spectacles if required, of 6/12 or worse. They had had a total of five accidents. Eleven non-diabetic patients continued to drive with visual acuity of6/12 or worse. Only one of this group of drivers had had an accident. Of the diabetic motorists treated with insulin, 86 were taking drugs for conditions other than diabetes mellitus. Twenty one (24-3%) of this subgroup had had accidents compared with 61 (22 8%) of drivers treated with insulin alone.
Hypoglycaemia among diabetic drivers-A total of 101 diabetic drivers admitted to having suffered symptoms that they recognised as indicating hypoglycaemia while driving during the preceding year. Forty six of these drivers reported that such an event had happened two to five times during the year, and 13 reported that it had happened more than five times. The number of hypoglycaemic episodes while driving during the past year was associated with the total number of accidents experienced by drivers during the five years ( 
or worse, five had declared their condition to the licensing centre. Nine had declared their condition to insurance companies, but only three of them had been required to provide a medical report. Two hundred and seventy eight drivers knew that driving while hypoglycaemic was an offence under the law, and 236 thought that insulin was a drug. One hundred and sixty three thought that driving heavy goods vehicles was prohibited. In the event of suffering hypoglycaemic symptoms while driving 286 drivers said that they would stop immediately and take glucose in some form. Seventy nine stated that they would also vacate the driving seat. Thirty five drivers said that they would take glucose but keep driving, while a further 24 said that they would either drive home carefully or drive to a cafe or shop. Two hundred and ninety four drivers permanently carried a supply of glucose or an equivalent in their car.
Attitudes of insurance companies to diabetic driversTwenty drivers had been refused motor insurance for reasons attributed to diabetes. This refusal followed a medical report from the driver's diabetic specialist or general practitioner in only two cases. Four others had been refused insurance for reasons unconnected with diabetes. All had subsequently obtained insurance, but one had failed to declare diabetes to the new company. Of eight non-diabetic drivers who had been refused insurance, only one stated that this was as a result of a medical condition. One hundred and seven diabetic drivers had had to pay increased premiums when they declared their diabetes to the motor insurance company. Of these drivers, 24 had not been required to provide a medical report. The group paying increased premiums had not had any more accidents than the group paying unchanged premiums (25 (23%) with accidents v 36 (27%)). Comparison of previous experience of severe hypoglycaemia, presence of warning symptoms of hypoglycaemia, alcohol use, and frequency of self monitoring of blood glucose concentrations showed no difference between the two groups. There were insufficient motoring convictions to include this variable in the analysis.
Discussion
We compared a sample of diabetic outpatients taking insulin with non-diabetic medical outpatients and found no significant difference in the number of current drivers in each group or in distance driven annually. There were no more road traffic accidents or convictions for motoring offences among diabetic drivers taking insulin even when differences in age, sex, driving experience, and alcohol consumption were taken into account. We know of no other controlled study in the United Kingdom, though a recent investigation from Scotland,5 in which Eadington and Frier reviewed the driving experiences of insulin dependent diabetic drivers, produced an overall accident rate similar to that found by us. In the Scottish study comparison was made with data from the Department ofTransport and insurance companies, giving accident rates for the general population; the rates for insulin dependent diabetic drivers were no higher. In a recent case-control study by Songer et al in the United States there were no more accidents among insulin treated diabetic drivers than in the general population.7 It is important to point out that in the present study and that of Eadington of our drivers admitted that an accident had ever been caused by hypoglycaemia. In Eadington and Frier's study nine accidents were attributed to hypoglycaemia, though these represented a substantial proportion (16%) of the total number of accidents recorded.
Overall, these findings are reassuring, though patients may underreport such events for fear of losing their licences.
A substantial number of drivers failed to notify the Driving and Vehicle Licensing Centre oftheir diabetes. As observed elsewhere,'6 more drivers declared their diabetes to the insurance company, though, ironically, third party insurance may be rendered invalid if the driver has not informed the licensing centre of the diabetes. The fear of failing to obtain a licence or insurance cover or of paying increased premiums is likely to deter diabetics from declaring their condition. Inconsistent decisions by insurance companies on cover and premiums made without medical reports may well encourage this.
The Road Traffic Acts 1988 require a licence holder to notify the secretary of state (in practice the licensing centre) of any disability that he or she has reason to believe will last more than three months. Such disabilities may be relevant or prospective, and diabetes may come into either of these categories, whatever its method of treatment. This advice appears on every driving licence. On receiving notification of diabetes the medical branch of the licensing centre assesses fitness to drive by using a questionnaire and with the advice of the applicant's diabetic specialist if considered necessary. Licences are then issued for one, two, or three years or in some cases revoked or refused. Failure to notify the authorities of a relevant or prospective disability is a criminal offence, punishable by a fine of up to £400 (Road Traffic Acts 1988).
We identified both diabetic and non-diabetic drivers with inadequate visual acuity by using a Snellen chart. The chart does not accurately mimic the standard eye test for number plates, but a corrected visual acuity of 6/12±2 is taken as about equal to the minimum required.'7 Among the diabetic drivers with poor vision most had failed to declare their diabetes to the licensing centre, thereby missing medical scrutiny. Although more diabetic drivers had informed their insurance company of their diabetes, the same companies failed to detect those with poor vision as they often did not require a medical report.
We found that a small number of vocational drivers had not notified the licensing authority oftheir diabetes and were therefore holding licences for which they might not be considered fit. 
Introduction
The role of endoscopic sphincterotomy in treating patients with stones in the common bile duct is now firmly established.' 2 Ninety per cent of patients with these stones can successfully be treated in this way.34 Technical difficulty in extracting stones with the aid of endoscopy increases with their size. Stones more than 2 cm in diameter are difficult to remove endoscopically. 5 Several methods have been used to fragment stones in the common duct to facilitate endscopic removal.6 Electrohydraulic lithotripsy utilises the principle of high pressure shock waves generated by a high voltage discharge and has been used to fragment urinary stones.7 It has been used in the biliary tract through the choledochoscope via a percutaneous transhepatic route8'0 or a T tube tract. " We describe our experience with electrohydraulic lithotripsy of stones in the common duct under direct vision using peroral choledochoscopy with the "mother and baby" endoscope system (Olympus Optical, Tokyo).
Patients and methods
During December 1988 and January 1989 we saw five patients (four women) with giant stones in the common duct in whom stone extraction by conventional methods (including mechanical lithotripsy) had failed. Their mean age was 66-4 years (range 48-82). The reasons for failure were inability to engage a large stone with the basket (three cases) and inability to open the lithotripsy basket in a duct packed with large stones (two). A total of nine large stones were seen in these five patients. The largest diameters ranged from 2-4 to 3-6 cm (mean 3-1 cm) and the smallest diameters frdm 2-2 to 3-0 cm (mean 2-6 cm). The sizes of the stones were measured from the radiograph by comparison with the diameter of the endoscope in the same radiograph.
All five patients presented with acute cholangitis. One required emergency nasobiliary drainage in the acute attack. All five patients had their sepsis controlled with antibiotics before attempted stone extraction. Sphincterotomy was performed in four patients, the other patient having had a sphincteroplasty two years previously.
INSTRUMENT
The Olympus mother and baby endoscope consists of an extra large duodenoscope (mother endoscope, XTJF-5 5) with an external diameter of 14-8 mm. It has a 5 5 mm instrument channel which admits a 4-1
